TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Trading 04-10 15:51:45 EDT

0.5730

-0.0226

-3.79%

High0.6178	Low0.5577	Vol68.10K
Open0.5988	D1 Closing0.5956	Amplitude10.09%
Mkt Cap25.52M	Tradable Cap12.41M	Total Shares44.53M
T/O39.90K	T/O Rate0.31%	Tradable Shares21.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":0.573,"timestamp":1775850678433,"preClose":0.5956,"halted":0,"volume":68104,"delay":0,"changeRate":-0.03794492948287452,"floatShares":21665700,"shares":44530500,"eps":-0.83,"marketStatus":"Trading","change":-0.0226,"latestTime":"04-10 15:51:45 EDT","open":0.5988,"high":0.6178,"low":0.5577,"amount":39904.61054248,"amplitude":0.100907,"askPrice":0.599,"askSize":100,"bidPrice":0.5679,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.83,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1775851200000},"marketStatusCode":2,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":0.5956,"preHourTrading":{"tag":"盘前","latestPrice":0.5859,"preClose":0.5956,"latestTime":"04:01 EDT","volume":3,"amount":1.7594000099999998,"timestamp":1775808062762,"change":-0.0097,"changeRate":-0.016286,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.5851,"preClose":0.5956,"latestTime":"18:03 EDT","volume":480,"amount":280.9005,"timestamp":1775772214625,"change":-0.0105,"changeRate":-0.017629,"amplitude":0.017629},"volumeRatio":0.381991,"impliedVol":1.6637,"impliedVolPercentile":0.264},"requestUrl":"/m/hq/s/TELA/tweets","defaultTab":"tweets","newsList":[{"id":"2622582737","title":"TELA Bio Is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2622582737","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622582737?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:46","pubTimestamp":1774619160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 09:46 ET (13:46 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847127","title":"Tela Bio price target lowered to $3 from $5 at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847127?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:45","pubTimestamp":1774604734,"startTime":"0","endTime":"0","summary":"Citizens analyst David Turkaly lowered the firm’s price target on Tela Bio (TELA) to $3 from $5 and keeps an Outperform rating on the shares. Tela ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-3-from-5-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-3-from-5-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622074178","title":"TELA Bio Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2622074178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622074178?lang=en_us&edition=fundamental","pubTime":"2026-03-25 22:09","pubTimestamp":1774447740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 10:09 ET (14:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622765027","title":"Tela Bio price target lowered to $2 from $4 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2622765027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622765027?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:47","pubTimestamp":1774435627,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on Tela Bio (TELA) to $2 from $4 and keeps a Buy rating on the shares. The firm said they posted decent Q...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-2-from-4-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-2-from-4-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622016185","title":"TELA Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016185","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016185?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:45","pubTimestamp":1774388739,"startTime":"0","endTime":"0","summary":"TELA Bio Inc reports results for the quarter ended December 31 - Earnings SummaryTELA Bio Inc TELA.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended December 31, higher","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL8N40C2WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622137840","title":"TELA Bio: Expects Full Year 2026 REV Growth of at Least 8% Over Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622137840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622137840?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:39","pubTimestamp":1774384791,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622013703","title":"TELA Bio: Expects Q1 2026 Revenue of About $18.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622013703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622013703?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:39","pubTimestamp":1774384791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C15V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622018793","title":"TELA Bio Q4 revenue rises 18% to USD 20.9 million as operating loss narrows 20.6% to USD 6.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622018793","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622018793?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:07","pubTimestamp":1774382867,"startTime":"0","endTime":"0","summary":"TELA Bio published a quarterly and annual earnings release, reporting Q4 revenue of USD 20.9 million, up 18%, and FY revenue of USD 80.3 million, up 16%.Q4 gross profit was USD 13.8 million and gross margin was 65.9%, compared with 63.6% a year earlier, reflecting lower excess and obsolete inventory adjustments as a percentage of revenue.Q4 operating expenses were USD 20.4 million, up 4.23%, driven by higher compensation costs including commissions and severance, as well as higher study and professional fees.Q4 net loss was USD 9 million and FY net loss was USD 38.8 million.Management guided for FY 2026 revenue growth of at least 8% and said it closed a credit facility for up to USD 70 million, including an initial USD 60 million loan and an additional USD 10 million available subject to conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLbG3g0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","LU2210150020.SGD","SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4112","IE00BN0W2V16.EUR","BK4585","SG9999014013.SGD","LU0314104364.USD","SG9999014039.USD","BK4198","IE00BN0W2T93.GBP","LU2095319765.USD","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622913013","title":"TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622913013","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622913013?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:05","pubTimestamp":1774382700,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., March  24, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261734/0/en/TELA-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621175439","title":"TELA Bio Inc  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2621175439","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621175439?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:44","pubTimestamp":1774039446,"startTime":"0","endTime":"0","summary":"TELA Bio Inc  expected to post a loss of18cents a share - Earnings Preview TELA Bio Inc TELA.OQ TELA.O is expected to  show a rise in quarterly revenue when it reports  results on March 24 for the per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4082C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618736699","title":"TELA Bio Inc. Files Initial Beneficial Ownership Statement for Chief Medical Officer Howard N. Langstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2618736699","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618736699?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:05","pubTimestamp":1773259537,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. filed an initial statement of beneficial ownership reporting holdings for Howard N. Langstein, Chief Medical Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL11mvRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618404966","title":"TELA Bio Schedules Fourth-Quarter and Full-Year 2025 Financial Results Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2618404966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618404966?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:05","pubTimestamp":1773173150,"startTime":"0","endTime":"0","summary":"TELA Bio will report fourth-quarter and full-year 2025 financial results on March 24, 2026. Management will host a conference call and webcast at 4:30 p.m. ET on March 24, 2026. The conference call registration is available at register online. A live webcast and replay will be available via the Events & Presentations page.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL6RqcSw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","BK4112","SG9999014039.USD","LU2095319765.USD","BK4588","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","TELA","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613381297","title":"TELA Bio Awards 8,550 RSUs to Newly Hired Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2613381297","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613381297?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621511,"startTime":"0","endTime":"0","summary":"TELA Bio’s board compensation committee approved inducement grants of restricted stock units covering 8,550 shares of common stock for three newly hired employees, with a grant date of Feb. 18, 2026. The awards vest in equal annual installments over four years, contingent on continued service through each vesting date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL5XTRvz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD","SG9999014039.USD","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","TELA","IE00BKPKM429.USD","BK4112","LU2210150020.SGD","LU0314104364.USD","SG9999014005.SGD","BK4198","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613526297","title":"TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613526297","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613526297?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621500,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Feb.  20, 2026  (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/20/3242139/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606344292","title":"TELA Bio Grants Restricted Stock Units to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2606344292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606344292?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:26","pubTimestamp":1769412388,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. has announced that its Compensation Committee has approved inducement grants of restricted stock units covering 14,250 shares of common stock to five newly hired employees. These restricted stock units will vest in equal annual installments over four years, contingent on each employee's continued service with the company through the respective vesting dates.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on January 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL27JJd9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","NDAQ","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","LU0314104364.USD","BK4198","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014005.SGD","SG9999014021.USD","TELA","IE00B64PRP62.GBP","BK4585","BK4588","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605285550","title":"TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285550","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285550?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:05","pubTimestamp":1769202300,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Jan.  23, 2026  (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3225062/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593316224","title":"Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly","url":"https://stock-news.laohu8.com/highlight/detail?id=2593316224","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593316224?lang=en_us&edition=fundamental","pubTime":"2025-12-23 00:56","pubTimestamp":1766422619,"startTime":"0","endTime":"0","summary":"Becton Dickinson BDX.N has been sued by a rival medical device manufacturer for allegedly thwarting competition in the U.S. market for surgical hernia mesh and causing patients and care providers to pay higher prices.The lawsuit by Tela Bio Inc TELA.O, filed on Friday in the federal court in Philadelphia, claims Becton Dickinson leveraged its dominance in two key product categories — permanent hernia mesh and resorbable hernia mesh — to exclude Tela Bio’s OviTex product.Hernia repairs are among the most widely performed operations nationwide, amounting to $12 billion annually, according to the lawsuit.Pennsylvania-based Tela Bio alleges Becton Dickinson violated antitrust law by punishing hospitals and other healthcare systems for buying Tela Bio’s product and using long-term contracts to lock purchasers into buying solely from Becton Dickinson.The case is Tela Bio Inc v. Becton, Dickinson & Co et al, U.S. District Court, Eastern District of Pennsylvania, No. 2:25-cv-07189.R.I. jury or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL6N3XS0AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985489474.SGD","BK4504","LU0433182093.SGD","LU1854103824.USD","BK4588","LU1150488218.USD","LU1894683264.USD","BK4585","BDX","LU0162691827.USD","LU0878866978.SGD","LU0068578508.USD","LU1489326972.SGD","LU1059921491.USD","LU0266013472.USD","LU1854104046.USD","LU1894683348.USD","LU1150488135.SGD","TELA","LU0130518102.USD","LU1201861165.SGD","LU0985320562.USD","LU0072461881.USD","LU0477156797.USD","LU0006061336.USD","IE00BFXG1179.USD","LU0511384066.AUD","LU0130103400.USD","LU0289739343.SGD","LU1571399168.USD","LU0648000940.SGD","LU0289961442.SGD","BK4198","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591008689","title":"TELA Bio Grants Restricted Stock Units to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2591008689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591008689?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:05","pubTimestamp":1765573510,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. has granted inducement restricted stock units covering 3,600 shares of its common stock to three newly-hired employees. The restricted stock units will vest in equal annual installments over four years, contingent upon each individual's continued service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL2fdwTx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BKPKM429.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BK4198","BK4585","LU0314104364.USD","BK4112","LU2210150020.SGD","NDAQ","SG9999014039.USD","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","TELA","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590450542","title":"TELA Bio Inc - Registers 2,000,000 Shares for Resale - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590450542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590450542?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:11","pubTimestamp":1765541513,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XI0H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588177470","title":"TELA Bio Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588177470?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:13","pubTimestamp":1764609180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 01, 2025 12:13 ET (17:13 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":-0.2926},{"period":"3month","weight":-0.4536},{"period":"6month","weight":-0.5921},{"period":"1year","weight":-0.4217},{"period":"ytd","weight":-0.4953}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.024622},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.021438},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.222765},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.055027},{"month":5,"riseRate":0.833333,"avgChangeRate":0.116033},{"month":6,"riseRate":0.5,"avgChangeRate":0.060581},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.037817},{"month":8,"riseRate":0.5,"avgChangeRate":-0.029417},{"month":9,"riseRate":0.5,"avgChangeRate":-0.04117},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.071357},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.011933},{"month":12,"riseRate":0.571429,"avgChangeRate":0.074086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}